• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一家大型都市肾脏服务机构中,慢性肾脏病(CKD)患者随年龄增长的谱(特征)。

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

作者信息

Mahmood Usman, Healy Helen G, Kark Adrian, Cameron Anne, Wang Zaimin, Abeysekera Rajitha, Hoy Wendy E

机构信息

Kidney Health Services, Metro North Hospital and Health Service, Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.

NHMRC CKD.CRE & CKD.QLD, Brisbane, QLD, Australia.

出版信息

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.

DOI:10.1186/s12882-017-0781-5
PMID:29282014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5745771/
Abstract

BACKGROUND

Aim of our study is to describe, in people with CKD, the demographic and clinical characteristics and outcomes with increasing age. The prevalence of CKD in Western populations, where longevity is the norm, is about 10-15%, but how age influence different characteristics of patients with CKD is largely not known.

METHODS

One thousand two hundred sixty-five patients enrolled in the CKD.QLD registry at the Royal Brisbane and Women's Hospital were grouped according to age at consent i.e. <35, 35-44, 45-54, 55-64, 65-74, 75-84, 85+ years age groups, and were followed till start of renal replacement therapy (RRT), death, discharge or the censor date of September 2015.

RESULTS

Age ranged from 17.6 to 98.5 years with medians of 70.1 and 69.9 years for males and females respectively: 7% were <35 years of age, with the majority (63%) >65 years old. The leading renal diagnoses changed from genetic real disease (GRD) and glomerulonephritis (GN) in the younger patients to renovascular disease (RVD) and hypertension (HTN) in older patients. With increasing age, there were often multiple renal disease diagnoses, more advanced stages of CKD, greater number of comorbidities, more frequent and more costly hospitalizations, and higher death rates. The rates of initiation of renal replacement therapy (RRT) rose from 4.5 per 100 person years in those age < 35 years to a maximum of 5.5 per 100 person years in 45-54 years age group and were lowest, at 0.5 per 100 person years in those >85 years. Mortality rates increased by age group from 1.3 to 17.0 per 100 person years in 35-44 year and 85+ year age groups respectively. Rates of hospitalization, length of stay and cost progressively increased from the youngest to eldest groups. Patients with diabetic nephropathy had highest incidence rate of RRT and death. The proportion of patients who lost more than 5mls/min/1.73m of eGFR during at least 12 months follow up increased from 13.3% in the youngest age group to 29.2% in the eldest.

CONCLUSION

This is the first comprehensive view, with no exclusions, of CKD patients seen in a public renal specialty referral practice, in Australia. The age distribution of patients encompasses the whole of adult life, with a broader range and higher median value than patients receiving RRT. Health status ranged from a single system (renal) disease in young adults through, with advancing age, renal impairment as a component of, or accompanying multisystem diseases, to demands and complexities of support of frail or elderly people approaching end of life. This great spectrum demands a broad understanding and capacity of renal health care providers, and dictates a need for a wider scope of health services provision incorporating multiple models of care.

摘要

背景

我们研究的目的是描述慢性肾脏病(CKD)患者的人口统计学和临床特征以及随着年龄增长的预后情况。在以长寿为常态的西方人群中,CKD的患病率约为10%-15%,但年龄如何影响CKD患者的不同特征在很大程度上尚不清楚。

方法

在皇家布里斯班妇女医院CKD.QLD登记处登记的1265例患者,根据同意参与研究时的年龄进行分组,即<35岁、35-44岁、45-54岁、55-64岁、65-74岁、75-84岁、85岁及以上年龄组,并随访至开始肾脏替代治疗(RRT)、死亡、出院或2015年9月的审查日期。

结果

年龄范围为17.6至98.5岁,男性和女性的年龄中位数分别为70.1岁和69.9岁:7%的患者年龄<35岁,大多数(63%)患者年龄>65岁。主要的肾脏诊断在年轻患者中从遗传性肾病(GRD)和肾小球肾炎(GN)转变为老年患者中的肾血管疾病(RVD)和高血压(HTN)。随着年龄的增长,通常会有多种肾脏疾病诊断、CKD更晚期阶段、更多的合并症、更频繁且费用更高的住院治疗以及更高的死亡率。肾脏替代治疗(RRT)的起始率从年龄<35岁者的每100人年4.5例上升至45-54岁年龄组的每100人年最高5.5例,而在85岁及以上者中最低,为每100人年0.5例。死亡率按年龄组分别从35-44岁年龄组的每100人年1.3例增加至85岁及以上年龄组的每100人年17.0例。住院率、住院时间和费用从最年轻组到最年长组逐渐增加。糖尿病肾病患者的RRT和死亡率发生率最高。在至少12个月的随访期间,估算肾小球滤过率(eGFR)下降超过5ml/min/1.73m²的患者比例从最年轻年龄组的13.3%增加至最年长组的29.2%。

结论

这是对澳大利亚一家公立肾脏专科转诊机构中所见CKD患者的首次全面观察,无任何排除情况。患者的年龄分布涵盖了整个成年期,范围比接受RRT的患者更广,中位数更高。健康状况从年轻成年人的单一系统(肾脏)疾病,随着年龄增长,发展为肾脏损害作为多系统疾病的一个组成部分或伴随疾病,再到接近生命末期的体弱或老年人的支持需求和复杂性。这种广泛的情况需要肾脏医疗保健提供者有广泛的理解和能力,并表明需要提供涵盖多种护理模式的更广泛的健康服务范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/adc903db989c/12882_2017_781_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/54da36ba8cd0/12882_2017_781_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/b3b887e3032d/12882_2017_781_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/7f2725befc87/12882_2017_781_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/dc34fa645eba/12882_2017_781_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/d6a53a5240f0/12882_2017_781_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/d104d55b8fa5/12882_2017_781_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/adc903db989c/12882_2017_781_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/54da36ba8cd0/12882_2017_781_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/b3b887e3032d/12882_2017_781_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/7f2725befc87/12882_2017_781_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/dc34fa645eba/12882_2017_781_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/d6a53a5240f0/12882_2017_781_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/d104d55b8fa5/12882_2017_781_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd7/5745771/adc903db989c/12882_2017_781_Fig7_HTML.jpg

相似文献

1
Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.在一家大型都市肾脏服务机构中,慢性肾脏病(CKD)患者随年龄增长的谱(特征)。
BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.
2
Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.慢性肾脏病,昆士兰州:来自澳大利亚昆士兰州地区的慢性肾脏病患者概况:注册报告。
Nephrology (Carlton). 2019 Dec;24(12):1257-1264. doi: 10.1111/nep.13567. Epub 2019 May 2.
3
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.转诊至肾脏病科的进展缓慢的老年慢性肾脏病患者肾替代治疗发生率较低:一项观察性研究。
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
4
Translating chronic kidney disease epidemiology into patient care--the individual/public health risk paradox.将慢性肾脏病流行病学转化为患者护理——个体/公共卫生风险悖论。
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii65-72. doi: 10.1093/ndt/gfr746. Epub 2012 Apr 24.
5
Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.慢性肾脏病进展的定义——在一个进行了6年随访的人群队列中的预测因素及其与肾脏替代治疗的关系
Nephrol Dial Transplant. 2014 Feb;29(2):333-41. doi: 10.1093/ndt/gft393. Epub 2013 Sep 29.
6
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
7
Does community-wide chronic kidney disease management improve patient outcomes?全社区慢性肾脏病管理是否能改善患者预后?
Nephrol Dial Transplant. 2014 Mar;29(3):644-9. doi: 10.1093/ndt/gft486. Epub 2013 Dec 10.
8
Does a medical management program for CKD patients postpone renal replacement therapy and mortality? A 5-year-cohort study.慢性肾脏病患者的医疗管理方案是否能延缓肾脏替代治疗和死亡?一项 5 年队列研究。
BMC Nephrol. 2012 Oct 22;13:138. doi: 10.1186/1471-2369-13-138.
9
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
10
Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.台湾慢性肾脏病多学科护理的效果:一项为期 3 年的前瞻性队列研究。
Nephrol Dial Transplant. 2013 Mar;28(3):671-82. doi: 10.1093/ndt/gfs469. Epub 2012 Dec 6.

引用本文的文献

1
Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD.慢性肾脏病老年患者的衰弱及疾病阶段的基线特征
Kidney Int Rep. 2024 Oct 15;10(1):120-133. doi: 10.1016/j.ekir.2024.10.009. eCollection 2025 Jan.
2
International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study.国际比较与欧洲各国首次肾移植受者特征的时间趋势:ERA 注册研究。
Nephrol Dial Transplant. 2024 Mar 27;39(4):648-658. doi: 10.1093/ndt/gfad189.
3
The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta.

本文引用的文献

1
International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.国际慢性肾脏病队列研究网络(iNET-CKD):一个全球性的慢性肾脏病队列研究网络。
BMC Nephrol. 2016 Sep 2;17(1):121. doi: 10.1186/s12882-016-0335-2.
2
Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.合并症是慢性肾脏病患者不良结局的驱动因素。
Kidney Int. 2015 Oct;88(4):859-66. doi: 10.1038/ki.2015.228. Epub 2015 Jul 29.
3
Australia and New Zealand Dialysis and Transplant Registry.
印度尼西亚肾衰竭的病因:雅加达三级护理中心的一项多中心研究。
Ann Glob Health. 2023 Jun 1;89(1):36. doi: 10.5334/aogh.4071. eCollection 2023.
4
Chronic kidney disease in public renal practices in Queensland, Australia, 2011-2018.2011-2018 年澳大利亚昆士兰州公立肾脏实践中的慢性肾脏病。
Nephrology (Carlton). 2022 Dec;27(12):934-944. doi: 10.1111/nep.14111. Epub 2022 Oct 9.
5
Comparison Between Statistical Model and Machine Learning Methods for Predicting the Risk of Renal Function Decline Using Routine Clinical Data in Health Screening.利用健康筛查中的常规临床数据预测肾功能下降风险的统计模型与机器学习方法的比较
Risk Manag Healthc Policy. 2022 Apr 26;15:817-826. doi: 10.2147/RMHP.S346856. eCollection 2022.
6
Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis.1990年至2019年高血压所致慢性肾脏病的疾病负担:一项全球分析。
Front Med (Lausanne). 2021 Jun 21;8:690487. doi: 10.3389/fmed.2021.690487. eCollection 2021.
7
The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease.阿拉伯胶对慢性肾脏病大鼠模型肠道微生物群组成及短链脂肪酸血浆水平的影响
Front Pharmacol. 2020 Dec 22;11:569402. doi: 10.3389/fphar.2020.569402. eCollection 2020.
8
Acute Deterioration of Kidney Function after Total Hip Arthroplasty.全髋关节置换术后肾功能急性恶化
Malays Orthop J. 2020 Jul;14(2):111-119. doi: 10.5704/MOJ.2007.020.
9
Risk Prediction for Early Chronic Kidney Disease: Results from an Adult Health Examination Program of 19,270 Individuals.风险预测早期慢性肾脏病:来自 19270 例成人健康体检计划的结果。
Int J Environ Res Public Health. 2020 Jul 10;17(14):4973. doi: 10.3390/ijerph17144973.
10
Spectrum and Clinical Characteristics of Renal Diseases in Ghanaian Adults: A 13-Year Retrospective Study.加纳成年人肾脏疾病的谱与临床特征:一项13年回顾性研究
Int J Nephrol. 2020 Apr 13;2020:8967258. doi: 10.1155/2020/8967258. eCollection 2020.
澳大利亚和新西兰透析与移植登记处。
Kidney Int Suppl (2011). 2015 Jun;5(1):39-44. doi: 10.1038/kisup.2015.8.
4
Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.转诊的中度慢性肾脏病患者的疾病负担和风险特征:德国慢性肾脏病(GCKD)队列的构成。
Nephrol Dial Transplant. 2015 Mar;30(3):441-51. doi: 10.1093/ndt/gfu294. Epub 2014 Sep 30.
5
Taming the chronic kidney disease epidemic: a global view of surveillance efforts.遏制慢性肾脏病流行:全球监测工作概览
Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.
6
The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.法国慢性肾脏病-肾脏流行病学与信息网络(CKD-REIN)队列研究。
Nephrol Dial Transplant. 2014 Aug;29(8):1500-7. doi: 10.1093/ndt/gft388. Epub 2013 Sep 24.
7
Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).队列资料简介:加拿大死亡、透析和心血管事件预测研究(CanPREDDICT)。
BMC Nephrol. 2013 Jun 11;14:121. doi: 10.1186/1471-2369-14-121.
8
Chronic kidney disease: global dimension and perspectives.慢性肾脏病:全球维度与展望。
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.
9
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
10
CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.澳大利亚昆士兰州慢性肾病监测和研究
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3(Suppl 3):iii139-45. doi: 10.1093/ndt/gfs258.